ArticleInfection2025

Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study.

Thomas Sahlström Månsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.